Table 1. Synopsis of major findings.
Day 7 | Day 14 | Day 21 | Day 28 | |
---|---|---|---|---|
VEGF-A | ↓ | NC | NC | |
LVA | ↑ | ↑ | ↑ | |
CD31 | ↓ | ↓ | ↓ | |
Sirius red | ↓ | ↓ | ↓ | NC |
TUNEL | ↑ | NC | NC | |
Caspase 3 | ↑ | ↑ | ||
Ki-67 | ↓ | ↓ | NC | |
RT-PCR | ||||
MMP-2 | ↓ | NC | ↑ | |
Pro-MMP-2 | ↓ | ↓ | ||
Active-MMP-2 | NC | ↓ | ||
RT-PCR | ||||
MMP-9 | ↓ | NC | NC | |
MMP-9 | NC | ↓ | ||
α-SMA | NC | ↓ | ↓ | |
VEGFR-1 | ↓ | NC | NC | |
HIF-1α | NC | ↓ | ||
VEGF-A staining | ↓ | ↓ |
Abbreviations: HIF-1α, hypoxia-inducible factor-1α LVA, lumen vessel area; MMP-2, matrix metalloproteinase 2; MMP-9, matrix metalloproteinase 9; NC, no change; RT-PCR, real-time PCR; α-SMA, α-smooth muscle actin; TUNEL, TdT-mediated dNTP nick end labeling; VEGF-A, vascular endothelial growth factor-A; VEGFR-1, vascular endothelial growth factor receptor 1.
NC is no change between the lentivirus (LV)–small hairpin RNA (shRNA)–VEGF-A-transduced specimens and controls.
The symbol ‘↑' indicates significant increase between the LV-shRNA-VEGF-A-transduced specimens and controls.
The symbol ‘↓' indicates significant decrease between the LV-shRNA-VEGF-A-transduced specimens and controls.